MX359453B - Composiciones y métodos útiles para aliviar los padecimientos relacionados con la edad. - Google Patents

Composiciones y métodos útiles para aliviar los padecimientos relacionados con la edad.

Info

Publication number
MX359453B
MX359453B MX2013010680A MX2013010680A MX359453B MX 359453 B MX359453 B MX 359453B MX 2013010680 A MX2013010680 A MX 2013010680A MX 2013010680 A MX2013010680 A MX 2013010680A MX 359453 B MX359453 B MX 359453B
Authority
MX
Mexico
Prior art keywords
compositions
enhancing
maintaining
age related
related maladies
Prior art date
Application number
MX2013010680A
Other languages
English (en)
Other versions
MX2013010680A (es
Inventor
Satyaraj Ebenezer
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013010680A publication Critical patent/MX2013010680A/es
Publication of MX359453B publication Critical patent/MX359453B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)

Abstract

La invención proporciona métodos y composiciones útiles para aliviar los padecimientos relacionados con la edad, la mejora y el mantenimiento de la función inmunológica, la mejora y el mantenimiento de la función cognitiva, la mejora y el mantenimiento de la fuerza muscular, la mejora y el mantenimiento del equilibrio, y reducir y mitigar el estrés oxidativo en un animal. Las composiciones comprenden una combinación de al menos dos de uno o más ácidos grasos insaturados (AGI); uno o más compuestos liberadores de óxido nítrico (CLON); uno o más agentes anti glicación; y calostro, y los métodos comprenden administrarle a un animal una cantidad terapéuticamente eficaz de las composiciones.
MX2013010680A 2011-03-18 2012-03-12 Composiciones y métodos útiles para aliviar los padecimientos relacionados con la edad. MX359453B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161465404P 2011-03-18 2011-03-18
PCT/US2012/028712 WO2012128982A2 (en) 2011-03-18 2012-03-12 Compositions and methods useful for ameliorating age related maladies

Publications (2)

Publication Number Publication Date
MX2013010680A MX2013010680A (es) 2013-10-03
MX359453B true MX359453B (es) 2018-09-28

Family

ID=46879965

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010680A MX359453B (es) 2011-03-18 2012-03-12 Composiciones y métodos útiles para aliviar los padecimientos relacionados con la edad.

Country Status (12)

Country Link
US (1) US10010566B2 (es)
EP (1) EP2685987B1 (es)
JP (1) JP2014515011A (es)
CN (1) CN104066342A (es)
AU (1) AU2012231351B2 (es)
BR (1) BR112013023770B1 (es)
CA (1) CA2830476C (es)
ES (1) ES2727043T3 (es)
MX (1) MX359453B (es)
RU (1) RU2600893C2 (es)
WO (1) WO2012128982A2 (es)
ZA (1) ZA201307770B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3016666T (pt) * 2013-06-13 2019-07-11 Smartfish As Formulação de óleo marinho que compreende resveratrol ou derivados do mesmo para utilizar no tratamento, retardamento e/ou prevenção de doença de alzheimer
US8974832B1 (en) * 2013-12-10 2015-03-10 Lifewave, Inc. Nutritional product composition for increasing human growth hormone and nitric oxide production
WO2016092479A1 (en) * 2014-12-10 2016-06-16 Subramaniam Vanangamudi Sulur A pharmaceutical formulation comprising resveratrol, benfotiamine and pyridoxamine, a process of making it and a method of treatment using it
WO2016100826A1 (en) * 2014-12-19 2016-06-23 Avelis Llc Mineral complex formulations for oral administration and methods for their use
US10660683B2 (en) * 2016-05-27 2020-05-26 In2Bones Usa, Llc Method for sterile packaging of K-wire and cap
AU2017270131B2 (en) * 2016-05-27 2023-03-09 Société des Produits Nestlé S.A. Nutritional composition for treating or preventing impaired mobility
WO2018066394A1 (ja) * 2016-10-04 2018-04-12 日本水産株式会社 筋肉を柔軟にするための組成物
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US20210128587A1 (en) * 2017-04-11 2021-05-06 Societe Des Produits Nestle S.A. Omega-3 fatty acid and vitamin d levels to identify and attenuate cognitive aging in individuals
WO2019036471A1 (en) 2017-08-14 2019-02-21 Axcella Health Inc. AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE
AR115585A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo
CN110801007A (zh) * 2019-12-17 2020-02-18 苟春虎 老年肌少症营养肽
AU2021336099A1 (en) * 2020-09-03 2023-02-23 Societe Des Produits Nestle Sa Compositions and methods for providing health benefits in an animal

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952033A (en) 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
DE69707413T3 (de) 1997-01-09 2009-07-02 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
AUPP327198A0 (en) * 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
AU783678B2 (en) 1999-09-07 2005-11-24 Societe Des Produits Nestle S.A. Method for improving the skin and coat of pets
AU777668B2 (en) 1999-09-22 2004-10-28 Societe Des Produits Nestle S.A. Method for increasing pet activity
DE60119515T2 (de) 2000-05-25 2007-05-24 Société des Produits Nestlé S.A. Probiotica für verwendung als haustierfutter
DE60122523T2 (de) 2000-05-26 2007-05-03 Société des Produits Nestlé S.A. Futter für haustiere
US20020119928A1 (en) * 2000-10-27 2002-08-29 Mcanalley Bill H. Dietary supplement compositions
US8669282B2 (en) * 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
US20060014773A1 (en) * 2001-04-19 2006-01-19 Mccleary Edward L Mental agility lozenge, edible strip, food or drink
US20040166206A1 (en) 2003-02-25 2004-08-26 Archibald William E. Vacuum packaged food products and methods of making same
EP1344458A1 (en) 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
US20070053955A1 (en) * 2005-08-26 2007-03-08 Nestec S.A. Compositions and methods for improving cellular survival and reducing apoptosis after ischemic episode in the brain
EP2322158B1 (en) * 2005-10-26 2020-06-10 Kao Corporation Resveratrol and/or grape leaf extract for energy metabolism activation
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
BRPI0709852A2 (pt) 2006-03-29 2011-07-26 Nestec Sa suplementos dietÉticos contendo probiàticos
JP2008189585A (ja) * 2007-02-02 2008-08-21 Qualicaps Co Ltd 水溶性硬質カプセル剤
JP2008214338A (ja) * 2007-02-08 2008-09-18 Shiseido Co Ltd 高次脳機能低下改善剤および遅延記憶低下改善剤
FR2913885B1 (fr) * 2007-03-22 2012-07-20 Univ Paris Descartes Utilisation de la citrulline pour le traitement des pathologies liees a une augmentation de la carbonylation des proteines
CA2701179C (en) * 2007-10-04 2021-03-16 Nestec S.A. Compositions and methods for enhancing cognitive function
US20100233304A1 (en) * 2008-01-04 2010-09-16 Yuanlong Pan Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
US20100056484A1 (en) 2008-08-26 2010-03-04 Scott Farese Dietary supplemental composition effective for enhancing cognitive performance, elevating mood and reducing oxidative stress
CN101433241A (zh) * 2008-12-05 2009-05-20 江苏星驰生物科技有限公司 配方牛初乳
WO2010095926A1 (en) * 2009-02-20 2010-08-26 N.V. Nutricia Use of reveratrol for preserving cognitive functioning
JP5606004B2 (ja) * 2009-03-31 2014-10-15 小林製薬株式会社 血中アルブミン量の増加促進または減少抑制用組成物

Also Published As

Publication number Publication date
ES2727043T3 (es) 2019-10-11
EP2685987B1 (en) 2019-04-24
AU2012231351B2 (en) 2016-03-10
CN104066342A (zh) 2014-09-24
MX2013010680A (es) 2013-10-03
WO2012128982A3 (en) 2014-04-24
EP2685987A2 (en) 2014-01-22
AU2012231351A1 (en) 2013-09-26
WO2012128982A2 (en) 2012-09-27
BR112013023770A2 (pt) 2016-12-06
BR112013023770B1 (pt) 2020-12-15
CA2830476A1 (en) 2012-09-27
US20140004205A1 (en) 2014-01-02
US10010566B2 (en) 2018-07-03
JP2014515011A (ja) 2014-06-26
RU2600893C2 (ru) 2016-10-27
CA2830476C (en) 2019-09-24
EP2685987A4 (en) 2014-08-20
ZA201307770B (en) 2015-04-29
RU2013146517A (ru) 2015-04-27

Similar Documents

Publication Publication Date Title
MX359453B (es) Composiciones y métodos útiles para aliviar los padecimientos relacionados con la edad.
MX346576B (es) Metodos y composiciones adecuados para promover piel sana.
PH12019501339A1 (en) Amino acid compositions and methods for the treatment of muscle diseases and disorders
MX2013007189A (es) Metodos y composiciones adecuados para manejar glucosa en sangre en animales.
GB2503852A (en) Compounds for the treatment of neuropsychiatric disorders
BR112016000072A2 (pt) composições orais
AU2016216741A1 (en) Compositions and methods of use of an inappetance-controlling compound
BR112014009962A2 (pt) anticorpos humanizados para inkt
MX2017005134A (es) Tratamiento del cáncer con inmunoestimuladores.
MX2015003048A (es) Tratamiento del trastorno de estres post-traumatico con mycobacterium aislado.
MX2019001977A (es) Metodos y composiciones para tratar esclerosis multiple y trastornos relacionados.
MX2015000398A (es) Formulaciones de laquinimod sin agente alcalinizante.
MX2018005825A (es) Celulas inmunes modificadas y usos de las mismas.
BR112014000634A2 (pt) métodos para tratamento de incontinência associada com atividade sexual
MX2019004364A (es) Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo.
EA201491532A1 (ru) Фармацевтические композиции для использования в комплексной терапии
MX2015010296A (es) Tratamiento de formas progresivas de esclerosis multiple con laquinimod.
MX2017009929A (es) Composiciones y métodos para metabolismo muscular mejorado.
MX2021006488A (es) Composiciones para mejorar la funcion sexual.
MX2013015419A (es) Dha y epa en la reduccion de estres oxidante.
WO2014031982A3 (en) Methods and compositions for treating pain
NZ723206A (en) A method of improving liver function
EA201492238A1 (ru) Композиция мизопростола
MX2016002714A (es) Composicion y metodo para tropicalizar chocolate.
MX2014003478A (es) Metodo y composiciones para reducir los niveles sericos de triacilgliceridos en seres humanos con una lipasa fungica.

Legal Events

Date Code Title Description
FG Grant or registration